Cargando…
Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
Psoriasis is a chronic immune-mediated skin disease affecting multiple systems, and tumor necrosis factor-α (TNF-α) plays a significant role in the initiation and progression of the disease process. Psoriasis has a high prevalence rate in the Western world, especially in the USA and Australia; in Ch...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661374/ https://www.ncbi.nlm.nih.gov/pubmed/31413544 http://dx.doi.org/10.2147/DDDT.S200147 |